BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GSK5471713 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GSK5471713\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07332455-11197@assetmemo.bio
DTSTAMP:20261121T005737Z
DTSTART;VALUE=DATE:20280324
DTEND;VALUE=DATE:20280325
SUMMARY:GSK5471713: Phase 1/2 readout est. (NCT07332455)
DESCRIPTION:GSK5471713\, phase 1/2.\nStudy: First-Time-in-Human Study of GS
 K5471713 in Adults With mCRPC\nEstimated primary completion: 24 March 2028
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/gsk5471713#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07332455
URL:https://assetmemo.bio/drug/gsk5471713#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
